Nonetheless, AML patients with complex karyotypes or displaying a FLT3 gene mutation, besides falling exclusively in the C2 group, proved to be extreme outliers in terms of very low NK cells percentages or high inhibitory receptors expression. This evidence concerns the gene FLT3 and acute myeloid leukemia.